Real-world data on palbociclib combo for advanced breast cancer in japan
NCT ID NCT05399329
First seen Apr 29, 2026 · Last updated May 16, 2026 · Updated 5 times
Summary
This study reviewed medical records of 693 Japanese patients with a certain type of advanced breast cancer (HR+/HER2-) who received palbociclib plus hormone therapy as their first or second treatment. Researchers wanted to see how long patients lived without the cancer getting worse and overall survival. No new treatments were given—this was just an observation of real-world results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aichi Cancer Center
Nagoya, 464-8681, Japan
-
Gifu University Hospital
Gifu, 501-1194, Japan
-
Hiroshima University Hospital
Hiroshima, 734-8551, Japan
-
Hokkaido Cancer Center
Sapporo, Hokkaido, 003-0804, Japan
-
Ishikawa Prefectural Central Hospital
Kanazawa, Ishikawa-ken, 920-8530, Japan
-
Japan Community Health care Organization Kurume General Hospital
Kurume, Fukuoka, 830-0013, Japan
-
Jichi Medical University Hospital
Shimotsuke, Tochigi, 329 0498, Japan
-
Kaizuka City Hospital
Kaizuka, Osaka, 597-0015, Japan
-
Kitasato University Hospital
Sagamihara, Kanagawa, 252-0329, Japan
-
Nagoya University Hospital
Nagoya, Aichi-ken, 466-8560, Japan
-
National Hospital Organization Osaka National Hospital
Osaka, 540-0006, Japan
-
National Hospital Organization Shikoku Cancer Center
Matsuyama, Ehime, 791-0280, Japan
-
Osaka International Cancer Institute
Osaka, Osaka, 541-8567, Japan
-
Osaka University Hospital
Suita, Osaka, 565-0871, Japan
-
Saitama Prefectural Cancer Center
Kita-adachi-gun, Saitama, 362-0806, Japan
-
Seirei Hamamatsu General Hospital
Hamamatsu, Shizuoka, 430-8558, Japan
-
Shizuoka Prefectural Hospital Organization
Shizuoka, 420-8527, Japan
-
Showa University Hospital
Tokyo, 142-8666, Japan
-
Tohoku University Hospital
Sendai, Miyagi, 980-8574, Japan
-
Tokai University Hospital
Kanagawa, 259-1193, Japan
Conditions
Explore the condition pages connected to this study.